Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
1-15 of 194
OCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Global Neurology AcademyOCEANIC-STROKE Results: Asundexian for Secondary Stroke Prevention After Acute Non-Cardioembolic Stroke or High-Risk TIA
Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Global Neurology AcademyBeyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
Evaluating Structured Interventions for Cognitive Support in MS
AudioAbstractsEvaluating Structured Interventions for Cognitive Support in MS
Optimizing Vitamin D Supplementation in MS Care
NeuroFrontiersOptimizing Vitamin D Supplementation in MS Care
The Role of Neurofilament Light Chain in MS Management
NeuroFrontiersThe Role of Neurofilament Light Chain in MS Management
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiersAddressing the Hidden Burden of Negative Symptoms in Schizophrenia
- advertisement
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiersHow Muscarinic Therapies Are Redefining Schizophrenia Care
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiersParkinson’s Research in Focus: Translating Science Into Clinical Progress
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiersDetecting Schizophrenia Early: Clinical Challenges and Future Directions
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiersOvercoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiersSupporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiersBeyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
- advertisement
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
On the Frontlines of MigraineCracking the Migraine Code: How AI May Transform Diagnosis and Treatment
Challenges and Opportunities in Migraine Management
On the Frontlines of MigraineChallenges and Opportunities in Migraine Management
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
